DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Eton Pharmaceuticals Q4 EPS $(0.15) Beats $(0.26) Estimate, Sales $459K Miss $670K Estimate

Eton Pharmaceuticals (NASDAQ:ETON) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.26) by 42.31 percent. This is a 93.3 percent increase over losses of $(2.24) per share

Benzinga · 03/05/2020 21:03

Eton Pharmaceuticals (NASDAQ:ETON) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.26) by 42.31 percent. This is a 93.3 percent increase over losses of $(2.24) per share from the same period last year. The company reported quarterly sales of $459 thousand which missed the analyst consensus estimate of $670 thousand by 31.49 percent.